Evidence map›Paper›PMID 33871470›Full record

ArticleThe Lancet regional health. Europe2021

Attack rates amongst household members of outpatients with confirmed COVID-19 in Bergen, Norway: A case-ascertained study.

Kanika Kuwelker, Fan Zhou, Bjørn Blomberg, Sarah Lartey, Karl Albert Brokstad, Mai Chi Trieu, Amit Bansal, Anders Madsen, Florian Krammer, Kristin Gi Mohn and 5 more

Open access · goldAbstract read
In one paragraph

Article in The Lancet regional health. Europe, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 4 pooled it
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 4 syntheses or guidelines pooled it, 53 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Symptom Burden and Immune Dynamics 6 to 18 Months Following Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2): A Case-control Study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 2 countries.

Kanika KuwelkerInfluenza Centre (KK, RJC, FZ, SL, MCT, AM, KGIM), Department of Clinical Science, University of Bergen, N-5021 Bergen, Norway.
Fan ZhouInfluenza Centre (KK, RJC, FZ, SL, MCT, AM, KGIM), Department of Clinical Science, University of Bergen, N-5021 Bergen, Norway.
Bjørn BlombergDepartment of Clinical Science (NL, BB), University of Bergen, N-5021 Bergen, Norway.
Sarah LarteyInfluenza Centre (KK, RJC, FZ, SL, MCT, AM, KGIM), Department of Clinical Science, University of Bergen, N-5021 Bergen, Norway.
Karl Albert BrokstadBroeglemann Research Laboratory (KAB), Department of Clinical Science, University of Bergen, N-5021 Bergen, Norway.
Mai Chi TrieuInfluenza Centre (KK, RJC, FZ, SL, MCT, AM, KGIM), Department of Clinical Science, University of Bergen, N-5021 Bergen, Norway.
Amit BansalInfluenza Centre (KK, RJC, FZ, SL, MCT, AM, KGIM), Department of Clinical Science, University of Bergen, N-5021 Bergen, Norway.
Anders MadsenInfluenza Centre (KK, RJC, FZ, SL, MCT, AM, KGIM), Department of Clinical Science, University of Bergen, N-5021 Bergen, Norway.
Florian KrammerDepartment of Microbiology (FK), Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States.
Kristin Gi MohnInfluenza Centre (KK, RJC, FZ, SL, MCT, AM, KGIM), Department of Clinical Science, University of Bergen, N-5021 Bergen, Norway.
Camilla TøndelDepartment of Paediatrics (CT), Haukeland University Hospital, N-5021 Bergen, Norway.
Dagrunn Waag LinchausenEmergency Clinic (DL), Bergen Municipality, Bergen N-5058, Norway.
Rebecca J CoxInfluenza Centre (KK, RJC, FZ, SL, MCT, AM, KGIM), Department of Clinical Science, University of Bergen, N-5021 Bergen, Norway.
Nina LangelandDepartment of Clinical Science (NL, BB), University of Bergen, N-5021 Bergen, Norway.
Bergen COVID-19 research group
Haukeland University Hospital · NOUniversity of Bergen · NOBergen Kommune · NOIcahn School of Medicine at Mount Sinai · USWestern Norway University of Applied Sciences · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHouseholds studies reflect the natural spread of SARS-CoV-2 in immunologically naive populations with limited preventive measures to control transmission.We hypothesise that seropositivity provides more accurate household attack rates than RT-PCR. Here, we investigated the importance of age in household transmission dynamics.

methodsWe enroled 112 households (291 participants) in a case-ascertained study in Bergen, Norway from 28th February to 4th April 2020, collecting demographic and clinical data from index patients and household members. SARS-CoV-2-specific antibodies were measured in sera collected 6-8 weeks after index patient nasopharyngeal testing to define household attack rates.

findingsThe overall attack rate was 45% (95% CI 38-53) assessed by serology, and 47% when also including seronegative RT-PCR positives. Serology identified a higher number of infected household members than RT-PCR. Attack rates were equally high in children (48%) and young adults (42%). The attack rate was 16% in asymptomatic household members and 42% in RT-PCR negative contacts. Older adults had higher antibody titres than younger adults. The risk of household transmission was higher when the index patient had fever (aOR 3.31 [95% CI 1.52-7.24];

interpretationSerological assays provide more sensitive and robust estimates of household attack rates than RT-PCR. Children are equally susceptible to infection as young adults. Negative RT-PCR or lack of symptoms are not sufficient to rule out infection in household members.

fundingHelse Vest (F-11628), Trond Mohn Foundation (TMS2020TMT05).

Identifiers

PMID33871470
PMCPMC8009692
OpenAlexW3149518894

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.